Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon Licenses Roche Reagent for PCR Assays

NEW YORK (GenomeWeb News) – Danish gene expression company Exiqon has licensed real-time PCR-related technology from Roche Diagnostics, Roche said today.
 
Under the agreement, Roche has granted Exiqon a non-exclusive license to use the SYBR Green reagent for detecting and quantitating PCR products in real-time PCR reactions.
 
Roche also noted that the two companies recently amended a 2005 license and distribution agreement allowing Roche to sell Exiqon’s Universal ProbeLibrary products.
 
Financial terms of the agreement were not released.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.